On the deal, Simpson Thacher acted for Oakley Capital; Hogan Lovells advised Assured Data Protection. Oakley Capital completed its £26 million investment in Assured Data Protection....
Oakley Capital’s £26 Million Investment In Assured Data Protection
Commvault’s Acquisiiton Of Clumio
Hogan Lovells advised Commvault on the deal. Commvault, a leading provider of cyber resilience and data protection solutions for the hybrid cloud, acquired Clumio, a technology...
Uranium Energy Corp’s Acquisition Of Rio Tinto’s Uranium Assets
Hogan Lovells advised Rio Tinto America Inc. on the deal. The US miner Uranium Energy Corp (UEC) has entered into an agreement to buy all of...
ASSA ABLOY’s Acquisition Of SKIDATA Group From Kudelski Group
On the deal, Hogan Lovells, Lenz & Staehelin and Baker McKenzie acted for Kudelski Group. Freshfields advised ASSA ABLOY on the acquisition. The Kudelski Group, a...
Hogan Lovells expands Boston footprint with addition of leading tax lawyer
Global law firm Hogan Lovells announced that Nicola Lemay has joined the firm’s Corporate & Finance practice as a partner in the Boston office. Lemay joins...
Ginkgo Bioworks’ Collaboration Agreement with Pfizer
Foley Hoag LLP represented Ginkgo Bioworks on the agreement. Ginkgo Bioworks (NYSE: DNA) announced a collaboration with Pfizer (NYSE: PFE) focused on the discovery of RNA-based drug...
Daewoong’s $336 Million Licensing Agreement with CS Pharmaceuticals
Foley Hoag advised Daewoong Pharmaceutical on the deal. South Korea’s Daewoong Pharmaceutical (“Daewoong”) secured an exclusive licensing agreement with CS Pharmaceuticals, a UK based multinational company focused...
Alcyone’s License and Collaboration Agreement with Biogen Inc.
Foley Hoag LLP represented Alcyone Therapeutics on the deal. Alcyone Therapeutics (Alcyone) announced the negotiation of a license and collaboration agreement with Biogen Inc. (Nasdaq: BIIB) to...
Lantheus Holdings’ $575 Million Notes Offering
Foley Hoag LLP advised Lantheus Holdings, Inc. on the deal. Lantheus Holdings, Inc. (NASDAQ: LNTH) announced a Rule 144A offering of $575 million aggregate principal amount...
Ginkgo Bioworks’ Collaboration Agreement with Merck
Foley Hoag LLP represented Ginkgo Bioworks on the deal. Ginkgo Bioworks, Inc. (NYSE: DNA), the leading horizontal platform for cell programming, closed a collaboration agreement with...
Ginkgo Bioworks’ Collaboration with Novo Nordisk
Foley Hoag LLP represented Ginkgo Bioworks, Inc. on the deal. Ginkgo Bioworks, Inc. (NYSE: DNA), the leading horizontal platform for cell programming, closed a collaboration agreement with...
Intellia Therapeutics’ Acquisition of a Stake in SparingVision
IN BRIEF: Bird & Bird, Foley Hoag LLP, Goodwin Procter, advised on the matter. Bird & Bird advised SparingVision SAS with a team including Emmanuelle Porte...